This retrospective study compared I-123-MIBG scintigraphy with FDG PET in 60 patients with neuroblastoma (113 paired studies performed within 2 weeks of each other). FDG PET was found to be more ...
Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001 Patients 1-30 years were eligible if they had relapsed or refractory ...
Treatment outcomes of pediatric and young adult sporadic desmoid tumors. Comparison of 18F-FDG-PET-CT and bone scintigraphy for evaluation of osseous metastases in newly diagnosed and recurrent ...
Neuroblastoma is one of the most common cancers in children and has limited treatment options. In a new study, researchers from Kanazawa University retrospectively analyzed children with refractory or ...
In addition to hypoxia, acidic extracellular pH (pH e) is recognised as one of the microenvironmental characteristics of solid tumours. A number of studies have examined ways to increase tumour ...
This trial is no longer recruiting patients. We hope to add results when they are available. This study is looking at combining mIBG, nivolumab and dinutuximab beta to treat neuroblastoma that has ...
High-dose 131I-mIBG therapy is a critical treatment option for high-risk neuroblastoma, a common solid tumors in children, especially when conventional therapies fail.
The treatment uses a radioactive form of iodine called iodine 131. The radioactive iodine circulates through your body in the bloodstream. The tumour cells pick up the radioactive iodine wherever they ...
Mumbai: A high-dose MIBG (metaiodobenzylguanidine) therapy for treating neuroblastoma, a type of cancer mostly found in children, will be provided at an affordable cost of Rs 7-8 lakh at a research ...
LOS ANGELES--(BUSINESS WIRE)--Children with high-risk neuroblastoma can now access a specialized, targeted radiation treatment called MIBG therapy at Children’s Hospital Los Angeles—one of the largest ...
A high-dose MIBG (metaiodobenzylguanidine) therapy for treating neuroblastoma, a type of cancer mostly found in children, will be provided at an affordable cost of Rs 7-8 lakh at a research body ...